JP5785098B2 - 単一ポリマー相系を用いる分離方法 - Google Patents

単一ポリマー相系を用いる分離方法 Download PDF

Info

Publication number
JP5785098B2
JP5785098B2 JP2011545321A JP2011545321A JP5785098B2 JP 5785098 B2 JP5785098 B2 JP 5785098B2 JP 2011545321 A JP2011545321 A JP 2011545321A JP 2011545321 A JP2011545321 A JP 2011545321A JP 5785098 B2 JP5785098 B2 JP 5785098B2
Authority
JP
Japan
Prior art keywords
phase
polymer
target
eopo
mab
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011545321A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012514637A (ja
JP2012514637A5 (https=
Inventor
アルスティネ，ヤメス ファン
アルスティネ，ヤメス ファン
シャナガール，ヤミル
フヨルス，ロルフ
ハル，マルティン
ニルセン，カミラ エストメール
ニルセン，カミラ エストメール
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytiva Sweden AB
Original Assignee
Amersham Bioscience AB
GE Healthcare Bio Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Bioscience AB, GE Healthcare Bio Sciences Corp filed Critical Amersham Bioscience AB
Publication of JP2012514637A publication Critical patent/JP2012514637A/ja
Publication of JP2012514637A5 publication Critical patent/JP2012514637A5/ja
Application granted granted Critical
Publication of JP5785098B2 publication Critical patent/JP5785098B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from milk
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2011545321A 2009-01-08 2010-01-07 単一ポリマー相系を用いる分離方法 Active JP5785098B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0900014 2009-01-08
SE0900014-2 2009-01-08
PCT/SE2010/050008 WO2010080062A1 (en) 2009-01-08 2010-01-07 Separation method using single polymer phase systems

Publications (3)

Publication Number Publication Date
JP2012514637A JP2012514637A (ja) 2012-06-28
JP2012514637A5 JP2012514637A5 (https=) 2013-02-21
JP5785098B2 true JP5785098B2 (ja) 2015-09-24

Family

ID=42316654

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011545321A Active JP5785098B2 (ja) 2009-01-08 2010-01-07 単一ポリマー相系を用いる分離方法

Country Status (7)

Country Link
US (1) US9115181B2 (https=)
EP (1) EP2373676B1 (https=)
JP (1) JP5785098B2 (https=)
CN (1) CN102272144B (https=)
AU (1) AU2010203836B2 (https=)
CA (1) CA2748807C (https=)
WO (1) WO2010080062A1 (https=)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
AU2007294731B2 (en) 2006-09-13 2014-04-17 Abbvie Inc. Cell culture improvements
BRPI0920572A8 (pt) 2008-10-20 2015-10-27 Abbott Lab Inativação viral durante a purificação dos anticorpos
NZ592095A (en) 2008-10-20 2013-01-25 Abbott Lab Isolation and purification of il-12 and tnf-alpha antibodies using protein a affinity chromatography
BR112013007237A2 (pt) 2010-11-05 2016-06-14 Hoffmann La Roche ''método para produzir um anticorpo anti-ig-1r''
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
WO2013039449A1 (en) * 2011-09-16 2013-03-21 Ge Healthcare Bio-Sciences Ab Plasma protein fractionation by sequential polyacid precipitation
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
HK1207960A1 (en) 2013-03-12 2016-02-19 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
US9828599B2 (en) 2013-09-18 2017-11-28 General Electric Company Methods of selecting binding-elements and uses thereof
US20150093839A1 (en) 2013-10-02 2015-04-02 General Electric Company Methods and systems for detection of target and applications thereof
US10359419B2 (en) 2013-10-02 2019-07-23 General Electric Company Methods for detection of target using affinity binding
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
KR101745455B1 (ko) * 2015-03-24 2017-06-09 포항공과대학교 산학협력단 수용액 이상계를 이용한 세포 밖 소포체의 다단계 정제방법
KR101761680B1 (ko) * 2015-03-31 2017-08-23 포항공과대학교 산학협력단 수용액 이상계를 이용한 세포 밖 소포체의 분리방법
WO2018165309A1 (en) 2017-03-08 2018-09-13 The Regents Of The University Of Michigan Analyte detection
EP4234710A3 (en) 2017-03-28 2023-11-01 Phase Scientific International, Ltd. Method for accurate diagnosis of a disease targeting biomarkers in liquid biopsy
SG11201909324WA (en) * 2017-06-01 2019-11-28 Yin To Chiu Phase separation behavior modifying agents for aqueous two-phase separation within porous material
US10450345B2 (en) 2017-06-09 2019-10-22 General Electric Company Method of isolation of polypeptide-aptamer-polymer conjugates
WO2019046563A1 (en) 2017-09-01 2019-03-07 Phase Diagnostics, Inc. METHOD AND DEVICE FOR USING AQUEOUS BIPHASE SYSTEMS (ATPS) TO IMPROVE THE DIAGNOSIS OF SEXUALLY TRANSMITTED INFECTIONS
ES2964100T3 (es) 2017-09-18 2024-04-04 Phase Scient International Ltd Método de utilización de un sistema acuoso bifásico para el aislamiento, purificación y/o concentración de fragmentos cortos de ácidos nucleicos
EP3740588A4 (en) 2018-01-19 2021-10-20 Phase Scientific International, Ltd. METHOD OF ISOLATION AND PURIFICATION OF NUCLEIC ACIDS USING A SOLID-LIQUID PHASE SYSTEM
WO2019143895A1 (en) 2018-01-19 2019-07-25 Yin To Chiu Spontaneous nucleic acid purification and concentration in a single step
WO2019143943A2 (en) 2018-01-19 2019-07-25 Yin To Chiu Composition and method for concentration and enrichment of nucleic acids
WO2019191497A1 (en) * 2018-03-30 2019-10-03 Blaze Bioscience, Inc. Systems and methods for simultaneous near-infrared light and visible light imaging
US12172108B2 (en) 2018-08-16 2024-12-24 Emd Millipore Corporation Closed bioprocessing device
EP4121530A1 (en) 2020-03-20 2023-01-25 Phase Scientific International, Ltd. Compositions and methods for ribonucleic acid extraction
CN112321704A (zh) * 2020-11-20 2021-02-05 华东理工大学 利用液态热响应型聚合物eo20po80分离纯化单克隆抗体
CN116840009A (zh) * 2023-07-01 2023-10-03 相达生物科技(深圳)有限公司 一种新型冠状病毒样本预处理方法
WO2025193698A1 (en) * 2024-03-11 2025-09-18 Michigan Technological University Purification of viral particles with two stage aqueous two-phase extraction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
CA2356704A1 (en) * 1998-12-30 2000-07-13 Folke Tjerneld Separation method utilizing liquid-liquid partition
US6544788B2 (en) * 2001-02-15 2003-04-08 Vijay Singh Disposable perfusion bioreactor for cell culture
WO2007073311A1 (en) * 2005-12-22 2007-06-28 Ge Healthcare Bio-Sciences Ab Preparation of biomolecules
WO2008156409A1 (en) * 2007-06-19 2008-12-24 Ge Healthcare Bio-Sciences Ab Separation method using polymer multi phase systems
JP2010530462A (ja) * 2007-06-19 2010-09-09 ジーイー・ヘルスケア・バイオ−サイエンシズ・アーベー ポリマー２相システムおよびその使用

Also Published As

Publication number Publication date
EP2373676A1 (en) 2011-10-12
JP2012514637A (ja) 2012-06-28
US9115181B2 (en) 2015-08-25
EP2373676B1 (en) 2017-04-19
AU2010203836B2 (en) 2015-05-28
WO2010080062A1 (en) 2010-07-15
CN102272144A (zh) 2011-12-07
EP2373676A4 (en) 2013-02-27
CA2748807A1 (en) 2010-07-15
CA2748807C (en) 2019-01-29
AU2010203836A1 (en) 2011-07-07
US20120010390A1 (en) 2012-01-12
CN102272144B (zh) 2014-09-17

Similar Documents

Publication Publication Date Title
JP5785098B2 (ja) 単一ポリマー相系を用いる分離方法
Molino et al. Different types of aqueous two‐phase systems for biomolecule and bioparticle extraction and purification
Hillebrandt et al. Integrated process for capture and purification of virus-like particles: enhancing process performance by cross-flow filtration
JP2022171925A (ja) 組換えａｄａｍｔｓ１３および他のタンパク質を精製する方法ならびにそれらの組成物
CA2179603C (en) Production of pharmaceutical-grade plasmid dna
US20120022239A1 (en) Precipitation of biomolecules with negatively charged polymers
AU2012309202B2 (en) Plasma protein fractionation by sequential polyacid precipitation
HK1246330A1 (zh) 蛋白质纯化
MX2013014773A (es) Procedimiento de purificacion de formas nativas o mutantes de la toxina difterica.
US9695216B2 (en) Materials and methods for removing endotoxins from protein preparations
JP5443175B2 (ja) 疎水性タンパク質を精製する方法
CN116583598A (zh) 纯化腺病毒的方法
JPWO2018043645A1 (ja) 活性炭を用いた蛋白質の精製方法
Rocha Aqueous two‐phase systems and monolithic chromatography as alternative technological platforms for virus and virus‐like particle purification
US20240327454A1 (en) Detergent and method for purifying a biotherapeutic
CN108611327B (zh) 一种猪圆环病毒2型病毒样颗粒的分离纯化方法
JP2021535221A (ja) 新規精製方法
US7157562B1 (en) Bioprocess for the production of recombinant anti-botulinum toxin antibody
EP2346891A1 (en) Clarification process at higher cell density
WO2026072101A1 (en) Method for purifying biomixtures
Labisch et al. Lab-Scale Tools for Advanced LV Downstream Processing
EA et al. Purification of a Recombinant TB1 Protein, a HIV Antigen

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121227

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20121227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140610

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140910

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150317

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150529

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150623

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150723

R150 Certificate of patent or registration of utility model

Ref document number: 5785098

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250